Abstract:Inflammation is the key for the initiation and progression of atherosclerosis. Accumulating evidence has revealed that an altered gut microbiome (dysbiosis) triggers both local and systemic inflammation to cause chronic inflammatory diseases, including atherosclerosis. There have been some microbiome-relevant pro-inflammatory mechanisms proposed to link the relationships between dysbiosis and atherosclerosis such as gut permeability disruption, trigger of innate immunity from lipopolysaccharide (LPS), and generation of proatherogenic metabolites, such as trimethylamine N-oxide (TMAO). Meanwhile, immune responses, such as inflammasome activation and cytokine production, could reshape both composition and function of the microbiota. In fact, the immune system delicately modulates the interplay between microbiota and atherogenesis. Recent clinical trials have suggested the potential of immunomodulation as a treatment strategy of atherosclerosis. Here in this review, we present current knowledge regarding to the roles of microbiota in contributing atherosclerotic pathogenesis and highlight translational perspectives by discussing the mutual interplay between microbiota and immune system on atherogenesis.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the interaction between the host immune system and the gut microbiota in the immunopathology of atherosclerosis. Specifically, the article focuses on how gut microbiota imbalance (i.e., dysbiosis) can trigger local and systemic inflammatory responses, thereby leading to chronic inflammatory diseases, especially atherosclerosis. In addition, the paper also discusses how the immune system responds to these changes by remodeling the composition and function of the microbiota, and the impact of this interaction on the development of atherosclerosis. The article emphasizes the importance of understanding this complex interaction in order to discover new targets for the prevention and treatment of atherosclerotic cardiovascular diseases. The key mechanisms mentioned in the paper include: 1. **Intestinal permeability disorder**: This can lead to the entry of bacterial components such as lipopolysaccharide (LPS) and peptidoglycan into the blood, triggering inflammation. 2. **Activation of the innate immune system**: Bacterial components such as LPS are recognized by immune cells through Toll - like receptors (TLRs), thereby activating the inflammatory response. 3. **Generation of microbial metabolites**: For example, metabolites such as trimethylamine N - oxide (TMAO) can inhibit reverse cholesterol transport (RCT) and induce systemic inflammation, further promoting the formation of atherosclerosis. 4. **Migration of immune cells**: Immune cells activated by the gut microbiota may migrate to distal blood vessels and organs, causing immunopathological changes. In summary, this review aims to summarize the current knowledge about the role of the gut microbiota in the pathogenesis of atherosclerosis and emphasizes the impact of the interaction between the gut microbiota and the immune system on the development of atherosclerosis.

Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

Intestinal Immunity and Gut Microbiota in Atherogenesis

Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)

Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism

The interaction between oral microbiota and gut microbiota in atherosclerosis

Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis

Cytokines and atherosclerosis: a comprehensive review of studies in mice

New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis

Impact of the gut microbiome on atherosclerosis

Intestinal Insights: The Gut Microbiome's Role in Atherosclerotic Disease: A Narrative Review

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases

Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review

The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases

Gut Microbiota And Atherosclerosis-Focusing On The Plaque Stability

The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review

The Gut Microbiome in Atherosclerotic Cardiovascular Disease.

[Chronic Inflammation, Autoimmunity and Atherosclerosis].

The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport